Oral Cancer Clinical Trial
Official title:
Assessment of Mandibular Bone Invasion With Magnetic Resonance Imaging (MRI) Using Sweep Imaging Fourier Transformation (SWIFT)
The primary objective of this study is to improve the diagnostic accuracy and specificity of
MRI in detecting the degree of bone involvement and invasion in oral cancer. The presence and
degree of bone invasion determines the extent of surgery and has great effect on the
morbidity of patients with oral cancer and bone/soft tissue tumors.
MRI scanning in 3 Tesla (3T) and 4Tesla (4T) MR magnet will be performed on up to 10 patients
with possible maxillofacial and/or mandibular bone invasion. We will then compare the
conventional imaging results of the patients with 3T and 4T MRI results and post operative
pathology results.
Unfortunately, detecting bone invasion and extension of bone involvement prior to surgery is
often difficult with the currently available imaging techniques. MRI with high contrast
resolution and the ability to perform multiplanar imaging plays an integral role in the
delineation of tumoral involvement of the bone. Although MRI is an excellent tool in the
assessment of bone invasion in carcinoma, its overestimation of cortical invasion and tumor
extent to the bone marrow have been a diagnostic challenge, leading to false positive
results. Like many of the musculoskeletal system tissues, cortical bone produces no signal
with conventional MRI techniques, limiting the characterization of image contrast and
differentiation of adjacent soft tissues. A novel MRI technique called Sweep Imaging with
Fourier Transformation (SWIFT) appears to be a suitable tool to overcome this challenge. The
main advantage of SWIFT is to obtain signal from the cortical bone. We believe that the SWIFT
technique will overcome the false positive results.
Patients enrolled in this study will be asked to come to the Center for Magnetic Resonance
Research (CMRR) at the University of Minnesota, Minneapolis, Minnesota for a scheduled MRI.
Brief scans will be obtained (less than 1 minute) to localize the area of interest. Longer
MRI scans (around 5-15 minutes each) will then be obtained. The total time required for
scanning will be about 1 hour.
To determine how well our MR images will predict the presence of mandibular invasion, we will
compare our results with clinical, operative, radiological and pathological findings. Thus,
patients will be asked to give permission to the investigators to access the relevant medical
records.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06031337 -
Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
|
||
Completed |
NCT00158678 -
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
|
Phase 3 | |
Completed |
NCT00933387 -
A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma
|
Phase 2 | |
Enrolling by invitation |
NCT05030597 -
Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
|
N/A | |
Completed |
NCT03682562 -
Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
|
||
Recruiting |
NCT03684707 -
Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions
|
Phase 4 | |
Recruiting |
NCT06130332 -
Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)
|
Phase 2 | |
Recruiting |
NCT04372914 -
Prevention of Oral DNA Damage by Black Raspberries
|
N/A | |
Active, not recruiting |
NCT03529422 -
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
|
Phase 2 | |
Recruiting |
NCT03686020 -
Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
|
||
Not yet recruiting |
NCT06060288 -
Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
|
||
Withdrawn |
NCT00951470 -
Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema
|
N/A | |
Completed |
NCT00964977 -
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
|
Phase 3 | |
Completed |
NCT01418118 -
Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
|
Phase 4 | |
Active, not recruiting |
NCT00232960 -
Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
|
N/A | |
Recruiting |
NCT05429099 -
Mandibular Reconstruction Preplanning (ViPMR)
|
Phase 2/Phase 3 | |
Completed |
NCT04614896 -
Use of Ultrasound for Measuring Size of Oral Tongue Cancers
|
N/A | |
Recruiting |
NCT03685409 -
Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions
|
Phase 3 | |
Completed |
NCT00402779 -
Erlotinib Prevention of Oral Cancer (EPOC)
|
Phase 3 | |
Recruiting |
NCT05153733 -
Improved Implant for Reconstruction Purposes After Mandibular Resection
|
N/A |